From: Targeting psychologic stress signaling pathways in Alzheimer’s disease
Biomarker studies | Description | Results | Comments |
---|---|---|---|
Bernardi et al. (2000) [42] | Serum levels of Cortisol and two neurosteroids, Allopregnanolone and dehydroepiandrosterone (DHEA), were compared in AD patients and controls | AD patients had significantly higher levels of cortisol and lower levels of Allopregnanolone compared to age matched controls | Clinical Dx of AD N = 12 |
Popp et al. (2015) [34] | Longitudinal prospective study examining serum and CSF levels of cortisol and Aβ in age matched controls, patients with mild cognitive impairment (MCI), and AD patients. | CSF cortisol levels are elevated in subjects with AD and MCI. Elevated CSF cortisol levels were associated with faster cognitive decline in MCI of the AD type. | Clinical Dx of AD |
Ennis et al. (2016) [35] | Prospective trial measuring once yearly a 24 h urinary cortisol level, over an average interval of 10.56 years | Elevated urinary cortisol level was related with a 1.31 times increase in AD risk, predicting increased AD risk an average of 6 years before onset. | Clinical Dx of AD. Participants that went on to be grouped in the “Future AD” group were 10 years older on average than control group |